This case study shows the benefits of having an independent Stop Loss carrier focused onthe right care at the right price.
This story demonstrates the success that Berkley Edge can have in helping control high-dollar claims.
Read our March 2024 update on the cell and gene therapy pipeline, with an in-depth look at Casgevy
U.S. employees are facing new challenges while on the road, according to a new survey sponsored by Berkley Accident and Health.
This case study shows the benefits of having an independent Stop Loss carrier focused on the right care at the right price.
Read our October 2023 report on the cell and gene therapy market
Read our April 2023 report on the cell and gene therapy market
Cell and Gene Therapy State Of The Market
Berkley Accident and Health shows the benefits of having a Provider Excess insurer that not only assists clients with high-dollar claims, but also focuses on the right care at the right price.
